Tech Company Financing Transactions

Reata Pharmaceuticals Funding Round

Reata Pharmaceuticals, based in Irving, secured $30.7 million from Cardinal Partners, Novo Ventures and Spinner Global Technology Fund.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

2801 Gateway Dr. 150
Irving, TX 75063
USA

Phone

(972) 865-2219

Website

www.reatapharma.com

Email Address

[email protected]

Overview

Reata Pharmaceuticals, Inc. (NASDAQ: RETA) is a biopharmaceutical company focused on developing novel treatments for cancer, inflammation, and neurodegenerative diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Warren Huff

        

Chief Financial Officer

Jason Wilson

        

Chief Medical Officer

Colin Meyer

        

VP - Bus. Development

Dawn Bir

        

VP - Bus. Development

Keith Ward

        

VP - Finance

Elaine Castellanos

        

VP - General Counsel

Michael Wortley

        

VP - Marketing

David Chapman

        

VP - R & D

Christian Wigley

        

VP - Regulatory Affairs

Joel Proksch

        

Browse more venture capital transactions:

Prev: 12/31/2008: Collaborative Software Initiative venture capital transaction
Next: 12/31/2008: Maria Health venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary